Welcome to our dedicated page for Alignment Healthcare news (Ticker: $ALHC), a resource for investors and traders seeking the latest updates and insights on Alignment Healthcare stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Alignment Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Alignment Healthcare's position in the market.
Alignment Healthcare, Inc. (NASDAQ: ALHC) reported strong first-quarter results with total revenue of $628.6 million, up 43.1% year-over-year. The company saw a 50.5% increase in Medicare Advantage membership to approximately 165,100 members. Adjusted gross profit was $57.3 million, while adjusted EBITDA was $(12.0) million. The outlook for the second quarter and fiscal year 2024 shows growth in health plan membership and revenues.
Alignment Healthcare, Inc. (NASDAQ: ALHC) will have its founder and CEO, John Kao, and chief financial officer, Thomas Freeman, presenting at two investor conferences in May 2024. The conferences include BofA Securities 2024 Health Care Conference on May 16 and Leerink Partners Healthcare Crossroads Conference on May 29. Interested individuals can access the webcast and replay of the presentations on Alignment's investor relations website.
